CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

ANROAlto Neuroscience, Inc.

NYSE · PHARMACEUTICAL PREPARATIONS
Last close $25.53 · 2026-09-30
ABOUT
ExchangeNYSE
SectorHealthcare
IndustryPHARMACEUTICAL PREPARATIONS
Market cap$1.00B
CountryUSA
RECENT INSIDER TRADES
  • 2026-10-05 · Smith Nicholas Conrad (PRESIDENT AND CFO) · OTHER
  • 2026-10-01 · Smith Nicholas Conrad (PRESIDENT AND CFO) · SELL
  • 2026-10-01 · Smith Nicholas Conrad (PRESIDENT AND CFO) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders121
Shares held31,795,476
Value$801.00M
Percent of shares outstanding81.02%
As of quarter end2026-06-30
RECENT NEWS
  • Alto Neuroscience president and CFO Smith sells $3.57m in shares
  • Alto Neuroscience at TD Cowen summit: pramipexole combo takes center stage
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Alto Neuroscience, Inc. (ANRO) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit